Companies / Opko Health, Inc.

Opko Health, Inc.

Nasdaq: COCPCIK 1412486BOTHELL, WA

Financials · FY2020

Revenue$2.01M
Net income$-8.83M
Total debt$49.94M
Cash$7.03M
Diluted EPS$-0.78
Shares outstanding19.3M

Ownership

19.3M shares outstanding · as of Aug 13, 2026
9.9%Insiders
Ownership
Insiders9.91%1,908,551
Institutions4.03%776,189
Public float86.06%16,578,460

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Phillip Frost, M.D.Director · 10% owner
9.91%1,908,551
Hassan FredDirector
——
Japour Anthony JDirector
——
Kornberg Roger D.Director
——
Lee SamCEOPresident and Co-CEO
——
Martin James JosephCEOCo-CEO and CFO
——
Pfenniger Richard C JrDirector
——
Rubin Steven DDirector
——

Institutional holders 29

View all →
HolderValue% of shares
Vanguard Group Inc$258.4K1.37%
Renaissance Technologies LLC$125.2K0.64%
Geode Capital Management, LLC$91.1K0.47%
BlackRock, Inc.$77.4K0.38%
T3 Companies, LLC$51.2K0.27%
DRW Securities, LLC$32.9K0.17%
Neuberger Berman Group LLC$31.2K0.17%
State Street Corporation$21.6K0.11%
XTX Topco Ltd$14.8K0.08%
Two Sigma Securities, LLC$12.5K0.07%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$7.8K+8K
+9.37%
90,231
0.47% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimCommon Stock$-2.1K-2K
-1.67%
123,928
0.64% of shares
low
Q3 2025
as of
Barclays PLC
13F manager
NewCommon Stock$20+16
16
<0.01% of shares
low
Q4 2025
as of
Barclays PLC
13F manager
ExitCommon Stock$-20-16
-100.00%
—
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon Stock$-9-9
-0.10%
9,083
0.05% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
COCPCommon StockEquity19188J409BBG000V27360